Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Trehalose on Survival in Critically Ill Children
IRCT20221129056657N4Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of trehalose in critical illness, sponsored by Mashhad University of Medical Sciences. Started Nov 2024; status: completed.
02
Drugs
trehalose
03
Conditions
critical illness
Beyond the preview
Go deeper on IRCT20221129056657N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221129056657N4.